Red blood cells as carriers of iron oxide-based contrast agents for diagnostic applications

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 1732-1750

  Antonelli, Antonella ^a   Magnani, Mauro ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Magnetic Particle Imaging MPI; Magnetic Resonance Imaging (MRI); Red Blood Cells (RBCs); SPIO Carriers; Superparamagnetic Iron Oxide (SPIO) nanoparticles

Indexed keywords

BLOOD; CELLS; CHEMOTHERAPY; IRON OXIDES; LIVER; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; PHYSIOLOGY; SUPERPARAMAGNETISM;

BLOOD VASCULAR SYSTEMS; DIAGNOSTIC APPLICATIONS; INTRAVENOUS ADMINISTRATION; MAGNETIC PARTICLE IMAGING; QUANTITATIVE COMPARISON; RED BLOOD CELL; SPIO-CARRIERS; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES;

DIAGNOSIS;

CONTRAST MEDIUM; FERRISTENE; FERUCARBOTRAN; FERUMOXSIL; FERUMOXYTOL; IRON OXIDE; MONOCRYSTALLINE IRON OXIDE NANOPARTICLE; NANOCRYSTAL; SUPERPARAMAGNETIC IRON OXIDE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VSOP C184; DRUG CARRIER; FERRIC ION; FERRIC OXIDE;

ANGIOGRAPHY; BONE MARROW; CIRCULATION TIME; DRUG DELIVERY SYSTEM; ERYTHROCYTE; ERYTHROCYTE MEMBRANE; HUMAN; KUPFFER CELL; LIVER DISEASE; NANOENCAPSULATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; REVIEW; SPLEEN; ANIMAL; CHEMISTRY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; METABOLISM; ULTRASTRUCTURE;

ANIMALS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ERYTHROCYTES; FERRIC COMPOUNDS; HUMANS;

EID: 84904878720     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1916     Document Type: Review

References (207)

1. O. Veiseh, J. Gunn, and M. Zhang, Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging. Adv. Drug Deliv. Rev. 62, 284 (2010).
2. A. Albanese, P. S. Tang, and W. C. W. Chan, The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu. Rev. Biomed. Eng. 14, 1 (2012).
3. W. H. De Jong and P. J. A. Borm, Drug delivery and nanoparticles: Applications and hazards. Int. J. Nanomedicine 3, 133 (2008).
4. M. D. Howard, E. D. Hood, B. Zern, V. V. Shuvaev, T. Grosser, and V. R. Muzykantov, Nanocarriers for vascular delivery of anti-inflammatory agents. Annu. Rev. Pharmacol. Toxicol. 54, 205 (2014).
5. D. Ho, X. Sun, and S. Sun, Monodisperse magnetic nanoparticles for theranostic applications. Acc. Chem. Res. 44, 875 (2011).
6. R. Bardhan, S. Lal, A. Joshi, and N. J. Halas, Theranostic nanoshells: From probe design to imaging and treatment of cancer. Acc. Chem. Res. 44, 936 (2011).
7. J. Xie, G. Liu, H. S. Eden, H. Ai, and X. Chen, Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc. Chem. Res. 44, 883 (2011).
8. R. Hao, R. Xing, Z. Xu, Y. Hou, S. Gao, and S. Sun, Synthesis, functionalization, and biomedical applications of multifunctional magnetic nanoparticles. Adv. Mater. 22, 2729 (2010).
9. D. Yoo, J. H. Lee, T. H. Shin, and J. Cheon, Theranostic magnetic nanoparticles. Acc. Chem. Res. 44, 863 (2011).
10. D. Chen, X. Xia, H. Gu, Q. Xu, J. Ge, Y. Li, N. Li, and J. Lu, pH-responsive polymeric carrier encapsulated magnetic nanoparticles for cancer targeted imaging and delivery. J. Mater. Chem. 21, 12682 (2011).
11. P. Howes, M. Green, A. Bowers, D. Parker, G. Varma, M. Kallumadil, M. Hughes, A. Warley, A. Brain, and R. Botnar, Magnetic conjugated polymer nanoparticles as bimodal imaging agents. J. Am. Chem. Soc. 132, 9833 (2010).
12. G. T. Herman, Fundamentals of computerized tomography: Image reconstruction from projection. Springer-Verlag, London (2009).
13. M. Srinivas, I. Melero, E. Kaempgen, C. G. Figdor, and I. J. M. de Vries, Cell tracking using multimodal imaging. Contrast Media Mol. Imaging 8, 432 (2013).
14. C. R. Berry and P. Garg, Perspectives in molecular imaging through translational research, human medicine, and veterinary medicine. Semin. Nucl. Med. 44, 66 (2014).
15. J. N. Tkacz, S. A. Anderson, and J. Soto, MR imaging in gastrointestinal emergencies. Radiographics 29, 1767 (2009).
16. R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, and A. G. Yodh, Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: A case study with comparison to MRI. Med. Phys. 32, 1128 (2005).
17. R. M. Botnar and M. R. Makowski, Cardiovascular magnetic resonance imaging in small animals. Prog. Mol. Biol. Transl. Sci. 105, 227 (2012).
18. R. M. Wong, D. A. Gilbert, K. Liu, and A. Y. Louie, Rapid size-controlled synthesis of dextran-coated, 64Cu-doped iron oxide nanoparticles. ACS Nano 6, 3461 (2012).
19. X. Chen, M. C. Cui, W. Deuther-Conrad, Y. F. Tu, T. Ma, Y. Xie, B. Jia, Y. Li, F. Xie, X. Wang, J. Steinbach, P. Brust, B. L. Liu, and H. M. Jia, Synthesis and biological evaluation of a novel 99mTc cyclopentadienyl tricarbonyl complex ([(Cp-R)99mTc(CO)3]) for sigma-2 receptor tumor imaging. Bioorg. Med. Chem. Lett. 22, 6352 (2012).
20. J. A. Jensen, Medical ultrasound imaging. Prog. Biophys. Mol. Biol. 93, 153 (2007).
21. V. Ntziachristos, A. G. Yodh, M. Schnall, and B. Chance, Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. PNAS 97, 2767 (2000).
22. H. Ding and F. Wu, Image guided biodistribution and pharmacokinetic studies of theranostics. Theranostics 2, 1040 (2012).
23. F. Nensa, T. D. Poeppel, K. Beiderwellen, J. Schelhorn, A. A. Mahabadi, R. Erbel, P. Heusch, K. Nassenstein, A. Bockisch, M. Forsting, and T. Schlosser, Hybrid PET/MR imaging of the heart: Feasibility and initial results. Radiology 268, 366 (2013).
24. H. Lusic and M. W. Grinstaff, X-ray-computed tomography contrast agents. Chem. Rev. 113, 1641 (2013).
25. M. X. Tang, H. Mulvana, T. Gauthier, A. K. Lim, D. O. Cosgrove, R. J. Eckersley, and E. Stride, Quantitative contrast-enhanced ultrasound imaging: A review of sources of variability. Interface Focus. 1, 520 (2011).
26. S. L. Pimlott and A. Sutherland, Molecular tracers for the PET and SPECT imaging of disease. Chem. Soc. Rev. 40, 149 (2011).
27. M. Salsano and G. Treglia, PET imaging using radiolabeled antibodies: Future direction in tumor diagnosis and correlate applications. Research and Reports in Nuclear Medicine 3, 9 (2013).
28. D. L. Dale and K. P. Willowson, An evidence-based review of quantitative SPECT imaging and potential clinical applications. J. Nucl. Med. 54, 83 (2013).
29. G. J. Strijkers, W. J. Mulder, G. A. van Tilborg, and K. Nicolay, MRI contrast agents: Current status and future perspectives. Anticancer Agents Med. Chem. 7, 291 (2007).
30. S. Kubaska, D. V. Sahani, S. Saini, P. F. Hahn, and E. Halpern, Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization. Clin. Radiol. 56, 410 (2001).
31. T. Allkemper, C. Bremer, L. Matuszewski, W. Ebert, and P. Reimer, Contrast-enhanced blood-pool MR angiography with optimized iron oxides: Effect of size and dose on vascular contrast enhancement in rabbits. Radiology 223, 432 (2002).
32. C. Corot, X. Violas, P. Robert, G. Gagneur, and M. Port, Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest. Radiol. 38, 311 (2003).
33. J. Bremerich, D. Bilecen, and P. Reimer, MR angiography with blood pool contrast agents. Eur. Radiol. 17, 3017 (2007).
34. B. Misselwitz, H. Schmitt-Willich, W. Ebert, T. Frenzel, and H. J. Weinmann, Pharmacokinetics of Gadomer-17, a new dendritic magnetic resonance contrast agent. MAGMA 12, 128 (2001).
35. L. A. Kramer, A. M. Cohen, K. M. Hasan, J. H. Heimbigner, A. D. Barreto, S. A. Brod, P. A. Narayana, and J. S. Wolinsky, Contrast enhanced MR venography with gadofosveset trisodium: Evaluation of the intracranial and extracranial venous system. J. Magn. Reson. Imaging (2013), Doi: 10.1002/jmri.24409.
36. I. Ergun, K. Keven, I. Uruc, Y. Ekmekçi, B. Canbakan, I. Erden, and O. Karatan, The safety of gadolinium in patients with stage 3 and 4 renal failure. Nephrol. Dial. Transplant. 21, 697 (2006).
37. P. H. Kuo, A. Abu-Alfa, R. Bucala, J. Griffith, K. Carlson, M. Girardi, J. Weinreb, and S. Cowper, MRI in the era of nephrogenic systemic fibrosis: Review, controversies and suggestions for risk reduction. Appl. Radiol. 38, 22 (2009).
38. D. E. Sosnovik and P. Caravan, Molecular MRI of the cardiovascular system in the post-NSF era. Curr. Cardiovasc. Imaging Rep. 6, 61 (2013).
39. E. Duguet, S. Vasseur, S. Mornet, and J. M. Devoisselle, Magnetic nanoparticles and their applications in medicine. A useful review on the applications of magnetic nanoparticles in biomedicine. Nanomedicine 1, 157 (2006).
40. Q. A. Pankhurst, N. K. T. Thanh, S. K. Jones, and J. Dobson, Progress in applications of magnetic nanoparticles in biomedicine. J. Phys. D: Appl. Phys. 42, 224001 (2009).
41. E. A. Neuwelt, B. E. Hamilton, C. G. Varallyay, W. R. Rooney, R. D. Edelman, P. M. Jacobs, and S. G. Watnick, Ultrasmall superparamagnetic iron oxides (USPIOs): A future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)? Kidney Int. 75, 465 (2009).
42. C. Rümenapp, B. Gleich, and A. Haase, Magnetic nanoparticles in magnetic resonance imaging and diagnostics. Pharm. Res. 29, 1165 (2012).
43. T. Neuberger, B. Schöpf, H. Hofmann, M. Hofmann, and B. von Rechenberg, Superparamagnetic nanoparticles for biomedical applications: Possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293, 483 (2005).
44. Y. X. J. Wang, Superparamagnetic iron oxide based MRI contrast agents: Current status of clinical application. Quant. Imaging Med. Surg. 1, 35 (2011).
45. E. A. Waters and S. A. Wickline, Contrast agents for MRI. Basic Res. Cardiol. 103, 114 (2008).
46. J. P. Fortin, C. Wilhelm, J. Servais, C. Ménager, J. C. Bacri, and F. Gazeau, Size-sorted anionic iron oxide nanomagnets as colloidal mediators for magnetic hyperthermia. J. Am. Chem. Soc. 129, 2628 (2007).
47. P. H. Linh, P. V. Thach, N. A. Tuan, N. C. Thuan, D. H. Manh, N. X. Phuc, and L. V. Hong, Magnetic fluid based on Fe3O4 nanoparticles: Preparation and hyperthermia application. J. Phys. Conf. Ser. 187, 012069 (2009).
48. S. C. McBain, H. H. P. Yiu, and J. Dobson, Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomedicine 3, 169 (2008).
49. L. Li, W. Jiang, K. Luo, H. Song, F. Lan, Y. Wu, and Z. Gu, Superparamagnetic iron oxide nanoparticles as MRI contrast agents for Non-invasive stem cell labeling and tracking. Theranostics 3, 595 (2013).
50. F. Scherer, M. Anton, U. Schillinger, J. Henke, C. Bergemann, A. Krüger, B. Gänsbacher, and C. Plank, Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9, 102 (2002).
51. M. Magnani, L. Galluzzi, and I. J. Bruce, The use of magnetic nanoparticles in the development of new molecular detection systems. J. Nanosci. Nanotechnol. 6, 2302 (2006).
52. W. S. Prestvik, A. Berge, P. C. Mork, P. M. Stenstad, and J. Ugelstad, Scientific and Clinical Application of Magnetic Carriers, edited by U. Häfeli, W. Schütt, J. Teller, and M. Zborowski, Plenum Press, New York (1997), pp. 11-36.
53. G. Amagliani, E. Omiccioli, A. Campo, I. J. Bruce, G. Brandi, and M. Magnani, Development of a magnetic capture hybridization-PCR assay for Listeria monocytogenes direct detection in milk samples. J. Appl. Microbiol. 100, 375 (2006).
54. S. Benderbous, C. Corot, P. Jacobs, and B. Bonnemain, Superparamagnetic agents. Physicochemical characteristics and preclinical imaging evaluation. Acad. Radiol. 3, S292 (1996).
55. B. Bonnemain, Superparamagnetic agents in magnetic resonance imaging: Physicochemical characteristics and clinical applications. A review. J. Drug Target 6, 167 (1998).
56. J. S. Weinstein, C. G. Varallyay, E. Dosa, S. Gahramanov, B. Hamilton, W. D. Rooney, L. L. Muldoon, and E. A Neuwelt, Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J. Cereb. Blood Flow Metab. 30, 15 (2010).
57. M. Rohrer, H. Bauer, J. Mintorovitch, M. Requardt, and H. J. Weinmann, Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest. Radiol. 40, 715 (2005).
58. H. B. Na, I. C. Song, and T. Hyeon, Inorganic nanoparticles for MRI contrast agents. Adv. Mater. 21, 2133 (2009).
59. R. Weissleder, D. D. Stark, B. L. Engelstad, B. R. Bacon, C. C. Compton, D. L. White, P. Jacobs, and J. Lewis, Superparamagnetic iron oxide: Pharmacokinetics and toxicity. AJR Am. J. Roentgenol. 152, 167 (1989).
60. M. E. Gindy and R. K. Prud'homme, Multifunctional nanoparticles for imaging, delivery and targeting in cancer therapy. Expert Opin. Drug Deliv. 6, 865 (2009).
61. C. Sun, J. S. Lee, and M. Zhang, Magnetic nanoparticles in MR imaging and drug delivery. Adv. Drug Deliv. Rev. 60, 1252 (2008).
62. E. Amstad, S. Zurcher, A. Mashaghi, J. Y. Wong, M. Textor, and E. Reimhult, Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5, 1334 (2009).
63. J. Meng, J. Fan, G. Galiana, R. T. Branca, P. L. Clasen, S. Ma, J. Zhou, C. Leuschner, C. S. S. R. Kumar, J. Hormes, T. Otiti, A. C. Beye, M. P. Harmer, C. J. Kiely, W. Warren, M. P. Haataja, and W. O. Soboyejo, LHRH-functionalized superparamagnetic iron oxide nanoparticles for breast cancer targeting and contrast enhancement in MRI. Mater. Sci. Eng. C 29, 1467 (2009).
64. J. E. Rosen, L. Chan, D. B. Shieh, and F. X. Gu, Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomedicine 8, 275 (2012).
65. M. Mahmoudi, S. Sant, B. Wang, S. Laurent, and T. Sen, Superparamagnetic iron oxide nanoparticles (SPIONs): Development, surface modification and applications in chemotherapy. Adv. Drug Deliv. Rev. 63, 24 (2011).
66. M. Muthiah, I. K. Park, and C. S. Cho, Surface modification of iron oxide nanoparticles by biocompatible polymers for tissue imaging and targeting. Biotechnol. Adv. 31, 1224 (2013).
67. M. Belting, S. Sandgren, and A. Wittrup, Nuclear delivery of macromolecules: Barriers and carriers. Adv. Drug Deliv. Rev. 5, 507 (2005).
68. M. Longmire, P. L. Choyke, and H. Kobayashi, Clearance properties of nano-sized particles and molecules as imaging agents: Considerations and caveats. Nanomedicine 3, 703 (2008).
69. P. Reimer and T. Balzer, Ferucarbotran (Resovist): A new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: Properties, clinical development, and applications. Eur. Radiol. 13, 1266 (2003).
70. L. Grazioli, M. P. Bondioni, L. Romanini, B. Frittoli, S. Gambarini, F. Donato, L. Santoro, and S. Colagrande, Superparamagnetic iron oxide-enhanced liver MRI with SHU 555 A (RESOVIST): New protocol infusion to improve arterial phase evaluation-a prospective study. J. Magn. Reson. Imaging 29, 607 (2009).
71. C. C. Berry and A. S. G. Curtis, Functionalisation of magnetic nanoparticles for applications in biomedicine. J. Phys. D: Appl. Phys. 36, R198 (2003).
72. C. Corot, P. Robert, J. M. Idéè, and M. Port, Recent advances in iron oxide nanocrystal technology for medical imaging. Adv. Drug Deliv. Rev. 58, 1471 (2006).
73. C. G. Millán, M. L. Marinero, A. Z. Castañeda, and J. M. Lanao, Drug, enzyme and peptide delivery using erythrocytes as carriers J. Control Release 95, 27 (2004).
74. M. Hamidi, A. Zarrin, M. Foroozesh, and S. Mohammadi-Samani, Applications of carrier erythrocytes in delivery of biopharmaceuticals. J. Control Release 118, 145 (2007).
75. Y. Godfrin, F. Horand, R. Franco, E. Dufour, E. Kosenko, B. E. Bax, A. Banz, O. A. Skorokhod, J. M. Lanao, V. Vitvitsky, E. Sinauridze, V. Bourgeaux, and K. C. Gunter, International seminar on the red blood cells as vehicles for drugs. Expert Opin. Biol. Ther. 12, 127 (2012).
76. M. Magnani, F. Pierigè, and L. Rossi, Erythrocytes as a novel delivery vehicle for biologics: From enzymes to nucleic acid-based therapeutics. Ther. Deliv. 3, 405 (2012).
77. M. Hamidi, M. Foroozesh, A. Zarrin, and A. Mehdipour, Erythrocytes: From oxygen delivery to drug delivery. Control. Rel. J. 1, 1 (2012).
78. M. Magnani, S. Serafini, A. Fraternale, A. Antonelli, S. Biagiotti, F. Pierigè, C. Sfara, and L. Rossi, Encyclopedia of Nanoscience and Nanotechnology, edited by H. S. Nalwa, American Scientific Publishers, Los Angeles (2011), Vol. 22, pp. 309-354.
79. S. Ravilla, B. R. Chandu, S. Nama, and B. Nagaveni, Erythrocytes as carrier for drugs, enzymes and peptides. JAPS 2, 166 (2012).
80. M. Magnani (ed.), Erythrocyte Engineering for Drug Delivery and Targeting, Landes Bioscience, Kluwer Academic/Plenum Publishers, New York (2003).
81. V. R. Muzykantov, Drug delivery by red blood cells: Vascular carriers designed by mother nature. Expert Opin. Drug Deliv. 7, 403 (2010).
82. L. Rossi, S. Serafini, F. Pierigé, A. Antonelli, A. Cerasi, A. Fraternale, L. Chiarantini, and M. Magnani, Erythrocyte-based drug delivery. Expert Opin. Drug Deliv. 2, 311 (2005).
83. V. R. Muzykantov, Drug delivery carriers on the fringes: Natural red blood cells versus synthetic multilayered capsules. Expert Opin. Drug Deliv. 10, 1 (2013).
84. T. A. Kolesnikova, A. G. Skirtach, and H. Möhwald, Red blood cells and polyelectrolyte multilayer capsules: Natural carriers versus polymer-based drug delivery vehicles. Expert Opin. Drug Deliv. 10, 47 (2013).
85. T. J. Merkel, S. W. Jones, K. P. Herlihy, F. R. Kersey, A. R. Shields, M. Napier, J. C. Lufta, H. Wu, W. C. Zamboni, A. Z. Wang, J. E. Bear, and J. M. DeSimone, Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles PNAS 108, 586 (2011).
86. K. Hayashi, K. Ono, H. Suzuki, M. Sawada, M. Moriya, W. Sakamoto, and T. Yogo, Electrosprayed synthesis of red-blood-cell-like particles with dual modality for magnetic resonance and fluorescence imaging. Small 6, 2384 (2010).
87. O. Kreft, R. Georgieva, H. Bäumler, M. Steup, B. Müller-Röber, G. B. Sukhorukov, and H. Möhwald, Red blood cell templated polyelectrolyte capsules: A novel vehicle for the stable encapsulation of DNA and proteins. Macromol. Rapid Commun. 27, 435 (2006).
88. S. E. Moya, R. Georgieva, H. Bäumler, W. Richter, and E. Donath, Composite lipid polyelectrolyte capsules templated on red blood cells: Fabrication and structural characterisation. Med. Biol. Eng. Comput. 41, 504 (2003).
89. R. Georgieva, S. Moya, E. Donath, and H. Bäumler, Permeability and conductivity of red blood cell templated polyelectrolyte capsules coated with supplementary layers. Langmuir 20, 1895 (2004).
90. E. Garbers, R. Mitlöhner, R. Georgieva, and H. Bäumler, Activity of immobilized trypsin in the layer structure of polyelectrolyte microcapsules (PEMC). Macromol. Biosci. 7, 1243 (2007).
91. N. Doshi, A. S. Zahr, S. Bhaskar, J. Lahann, and S. Mitragotri, Red blood cell-mimicking synthetic biomaterial particles. PNAS 106, 21495 (2009).
92. K. H. Roh, D. C. Martin, and J. Lahann, Biphasic janus particles with nanoscale anisotropy. Nat. Mater. 4, 759 (2005).
93. C. M. J. Hu, L. Zhang, S. Aryal, C. Cheung, R. H. Fang, and L. Zhang, Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. PNAS 108, 10980 (2011).
94. M. Chang, J. K. Hsiao, M. Yao, L. Y. Chien, S. C. Hsu, B. S. Ko, S. T. Chen, H. M. Liu, Y. C. Chen, C. S. Yang, and D. M. Huang, Homologous RBC-derived vesicles as ultrasmall carriers of iron oxide for magnetic resonance imaging of stem cells. Nanotechnology 21, 235103 (2010).
95. B. Bahmani, D. Bacon, and B. Anvari, Erythrocyte-derived phototheranostic agents: Hybrid nano-vesicles containing indocyanine green for near infrared imaging and therapeutic applications. Scientific Reports 3, 2180 (2013).
96. M. Laurencin, N. Cam, T. Georgelin, O. Clément, G. Autret, J. M. Siaugue, and C. Ménager, Human erythrocytes covered with magnetic core-shell nanoparticles for multimodal imaging. Adv. Healthc. Mater. 2, 1209 (2013).
97. T. D. Mai, F. d'Orlyé, C. Ménager, A. Varenne, and J. M. Siaugue, Red blood cells decorated with functionalized core-shell magnetic nanoparticles: Elucidation of the adsorption mechanism. Chem. Commun. 49, 5393 (2013).
98. S. Serafini. L. Rossi, A. Antonelli, A. Fraternale, A. Cerasi, R. Crinelli, L. Chiarantini, G. F. Schiavano, and M. Magnani, Drug delivery through phagocytosis of red blood cells. Transfus. Med. Hemother. 31, 92 (2004).
99. M. A. Milanick, S. Ritter, and K. Meissner, Engineering erythrocytes to be erythrosensors: First steps. Blood Cells Mol. Dis. 47, 100 (2011).
100. S. C. Ritter, M. A. Milanick, and K. E. Meissner, Encapsulation of FITC to monitor extracellular pH: A step towards the development of red blood cells as circulating blood analyte biosensors. Biomed. Opt. Express 2, 2012 (2011).
101. R. Flower, E. Peiretti, M. Magnani, L. Rossi, S. Serafini, Z. Gryczynski, and I. Gryczynski, Observation of erythrocyte dynamics in the retinal capillaries and choriocapillaris using ICG-loaded erythrocyte ghost cells. Invest. Ophthalmol. Vis. Sci. 49, 5510 (2008).
102. S. Ahn, S. Y. Jung, E. Seo, and S. J. Lee, Gold nanoparticle-incorporated human red blood cells (RBCs) for X-ray dynamic imaging. Biomaterials 32, 7191 (2011).
103. U. Sprandel, D. J. Lanz, and W. von Hörsten, Magnetically responsive erythrocyte ghosts. Methods Enzymol. 149, 301 (1987).
104. U. Sprandel, A. R. Hubbard, and R. A. Chalmers, In vitro studies on resealed erythrocyte ghosts as protein carriers. Res. Exp. Med. (Berl.) 175, 239 (1979).
105. J. DeLoach and G. Ihler, A dialysis procedure for loading erythrocytes with enzymes and lipids. Biochim. Biophys. Acta 496, 136 (1977).
106. S. K. Jain and S. P. Vyas, Magnetically responsive diclofenac sodium-loaded erythrocytes: Preparation and in vitro characterization. J. Microencapsul. 11, 141 (1994).
107. S. P. Vyas and S. K. Jain, Preparation and in vitro characterization of a magnetically responsive ibuprofen-loaded erythrocytes carrier. J. Microencapsul. 11, 19 (1994).
108. M. C. Rechsteiner, Uptake of proteins by red blood cells. Exp. Cell Res. 93, 487 (1975).
109. E. Pitt, C. M. Johnson, D. A. Lewis, D. A. Jenner, and R. E. Offord, Encapsulation of drugs in intact erythrocytes: An intravenous delivery system. Biochem. Pharmacol. 32, 3359 (1983).
110. W. N. Field, M. D. Gamble, and D. A. Lewis, A comparison of the treatment of thyroidectomized rats with free thyroxine and thyroxine encapsulated in erythrocytes. Int. J. Pharmacol. 51, 175 (1989).
111. U. Sprandel and N. Zöllner, Osmotic fragility of drug carrier erythrocytes. Exp. Med. 185, 77 (1985).
112. N. M. Orekhova, R. S. Akchurin, A. A. Belyaev, M. D. Smirnov, S. E. Ragimov, and A. N. Orekhov, Local prevention of thrombosis in animal arteries by means of magnetic targeting of aspirin-loaded red cells. Thromb. Res. 57, 611 (1990).
113. Yu. N. Danilov, S. A. Rudchenko, G. P. Samokhin, A. N. Orekhov, M. B. Il'ina, S. Ya. Makhmudov, N. B. Dobrova, V. L. Buyanovskii, and A. V. Pokrovskii, Concentration of erythrocyte-based magnetic carriers in the bloodstream. B. Exp. Biol. Med. 100, 1684 (1985).
114. C. Cinti, M. Taranta, I. Naldi, and S. Grimaldi, Newly engineered magnetic erythrocytes for sustained and targeted delivery of anticancer therapeutic compounds. Plos One 6, e17132 (2011).
115. R. Panchal, A. Patel, M. Patel, and H. Jain, Resealed erythrocytes: A novel drug delivery system. IJPI's Journal of Pharmaceutics and Cosmetology 1, 20 (2011).
116. G. S. Banker and C. T. Rhodes (eds.), Modern Pharmaceutics, 4th edn., Marcel Dekker Inc., New York (2002).
117. M. Brahler, R. Georgieva, N. Buske, A. Müller, S. Müller, J. Pinkernelle, U. Teichgräber, A. Voigt, and H. Bäumler, Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. Nano Lett. 6, 2505 (2006).
118. N. Stenberg, R. Georgieva, K. Duft and H. Bäumler, Surface-modified loaded human red blood cells for targeting and delivery of drugs. J. Microencapsul. 29, 9 (2012).
119. M. Magnani, L. Rossi, A. Fraternale, M. Bianchi, A. Antonelli, R. Crinelli, and L. Chiarantini, Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther. 9, 749 (2002).
120. A. Antonelli, C. Sfara, L. Mosca, E. Manuali, and M. Magnani, New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles. J. Nanosci. Nanotechnol. 8, 2270 (2008).
121. A. Antonelli, C. Sfara, E. Manuali, I. J. Bruce, and M. Magnani, Encapsulation of superparamagnetic nanoparticles into red blood cells as new carriers of MRI contrast agents. Nanomedicine 6, 211 (2011).
122. G. M. Ihler and H. C. Tsang, Hypotonic hemolysis methods for entrapment of agents in resealed erythrocytes. Methods Enzymol. 149, 221 (1987).
123. Y. W. Jun, J. H. Lee, and J. Cheon, Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew. Chem. Int. Ed. Engl. 47, 5122 (2008).
124. Y. X. Wang, S. M. Hussain, and G. P. Krestin, Superparamagnetic iron oxide contrast agents: Physicochemical characteristics and applications in MR imaging. Eur. Radiol. 11, 2319 (2001).
125. C. Zhang, T. Liu, J. Gao, Y. Su, and C. Shi, Recent development and application of magnetic nanoparticles for cell labeling and imaging. Mini. Rev. Med. Chem. 10, 193 (2010).
126. A. Antonelli, C. Sfara, S. Battistelli, B. Canonico, M. Arcangeletti, E. Manuali, S. Salamida, S. Papa, and M. Magnani, New strategies to prolong the in vivo life span of iron-based contrast agents for MRI. Plos One 8, e78542 (2013).
127. M. Magnani and A. Antonelli, Delivery of contrasting agents for magnetic resonance imaging, International Patent Application No. PCT/EP2007/006349, July 3 (2007).
128. M. Magnani, M. Laguerre, L. Rossi, M. Bianchi, P. Ninfali, F. Mangani, and C. Ropars, In vivo accelerated acetaldehyde metabolism using acetaldehyde dehydrogenase-loaded erythrocytes. Alcohol Alcohol. 25, 627 (1990).
129. B. E. Bax, M. D. Bain, P. J. Talbot, E. J. Parker-Williams, and R. A. Chalmers, Survival of human carrier erythrocytes in vivo. Clin. Sci. 96, 171 (1999).
130. A. E. Grigoriadis, Z. Q. Wang, M. G. Cecchini, W. Hofstetter, R. Felix, H. A. Fleisch, and E. F. Wagner, c-Fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443 (1994).
131. K. S. Selander, J. Mönkkönen, E. K. Karhukorpi, P. Härkönen, R. Hannuniemi, and H. K. Väänänen, Characteristics of clodronate-induced apoptosis in osteoclasts and macrophages. Mol. Pharmacol. 50, 1127 (1996).
132. L. Rossi, S. Serafini, A. Antonelli, F. Pierigé, A. Carnevali, V. Battistelli, M. Malatesta, E. Balestra, R. Caliò, C. F. Perno, and M. Magnani, Macrophage depletion induced by clodronate-loaded erythrocytes. J. Drug Target. 13, 99 (2005).
133. S. Serafini, A. Fraternale, L. Rossi, A. Casabianca, A. Antonelli, M. F. Paoletti, C. Orlandi, F. Pierigè, C. Sfara, G. F. Schiavano, and M. Magnani, Effect of macrophage depletion on viral DNA rebound following antiretroviral therapy in a murine model of AIDS (MAIDS). Antiviral Res. 81, 93 (2009).
134. A. Antonelli, C. Sfara, E. Manuali, S. Salamida, G. Louin, and M. Magnani, Medical Imaging 2013: Biomedical Applications in Molecular, Structural, and Functional Imaging, edited by J. B. Weaver and R. C. Molthen, SPIE, Bellingham (2013) Vol. 8672, p. 86721D.
135. M. Port and D. La Barre, Novel compositions magnetic particles covered with GEM-bisphosphonate. U.S. Patent 2004/0253181A1, December 16 (2004).
136. M. Di Marco, I. Guilbert, M. Port, C. Robic, P. Couvreur, and C. Dubernet, Colloidal stability of ultrasmall superparamagnetic iron oxide (USPIO) particles with different coatings. Int. J. Pharm. 331, 197 (2007).
137. M. Sigovan, L. Boussel, A. Sulaiman, D. Sappey-Marinier, H. Alsaid, C. Desbleds-Mansard, D. Ibarrola, D. Gamondès, C. Corot, E. Lancelot, J. S. Raynaud, V. Vives, C. Laclédère, X. Violas, P. C. Douek, and E. Canet-Soulas, Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: Initial experience in animal model. Radiology 252, 401 (2009).
138. S. Kinner, S. Maderwald, J. Albert, N. Parohl, C. Corot, P. Robert, H. A. Baba, and J. Barkhausen, Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes. Invest. Radiol. 47, 511 (2012).
139. A. Boni, D. Ceratti, A. Antonelli, C. Sfara, M. Magnani, E. Manuali, S. Salamida, A. Gozzi, and A. Bifone, USPIO-loaded red blood cells as a biomimetic MR contrast agent: A relaxometric study. Contrast Media Mol. Imaging (in press).
140. M. F. Casula, A. Corrias, P. Arosio, A. Lascialfari, T. Sen, P. Floris, and I. J. Bruce, Design of water-based ferrofluids as contrast agents for magnetic resonance imaging. J. Colloid Interface Sci. 357, 50 (2011).
141. D. E. Markov, H. Boeve, B. Gleich, J. Borgert, A. Antonelli, C. Sfara, and M. Magnani, Human erythrocytes as nanoparticle carriers for magnetic particle imaging. Phys. Med. Biol. 55, 6461 (2010).
142. S. G. Kim, N. Harel, T. Jin, T. Kim, P. Lee, and F. Zhao, Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles. NMR Biomed. 26, 949 (2013).
143. T. Barrett, M. Brechbiel, M. Bernardo, and P. L. Choyke, MRI of tumor angiogenesis. J. Magn. Reson. Imaging 26, 235 (2007).
144. F. A. Jaffer, P. Libby, and R. Weissleder, Molecular imaging of cardiovascular disease. Circulation 116, 1052 (2007).
145. M. Magnani, L. Rossi, M. D'ascenzo, I. Panzani, L. Bigi, and A. Zanella, Erythrocyte engineering for drug delivery and targeting. Biotechnol. Appl. Biochem. 28, 1 (1998).
146. Y. Godfrin, Lysis/resealing process and device for incorporating an active ingredient in erythrocytes, International Patent Application No. PCT/IB2005/002323, February 16 (2006).
147. M. Castro, D. Knafelz, L. Rossi, M. I. Ambrosini, B. Papadatou, G. Mambrini, and M. Magnani, Periodic treatment with autologous erythrocytes loaded with dexamethasone 21-phosphate for fistulizing pediatric Crohn's disease: Case report. J. Pediatr. Gastroenterol. Nutr. 42, 313 (2006).
148. M. Castro, L. Rossi, B. Papadatou, F. Bracci, D. Knafelz, M. I. Ambrosini, A. Calce, S. Serafini, G. Isacchi, F. D'Orio, G. Mambrini, and M. Magnani, Long-term treatment with autologous red blood cells loaded with dexamethasone 21-phosphate in pediatric patients affected by steroid-dependent Crohn disease. J. Pediatr. Gastroenterol. Nutr. 44, 423 (2007).
149. F. Bossa, A. Latiano, L. Rossi, M. Magnani, O. Palmieri, B. Dallapiccola, S. Serafini, G. Damonte, E. De Santo, A. Andriulli, and V. Annese, Erythrocyte-mediated delivery of dexamethasone in patients with mild-to-moderate ulcerative colitis, refractory to mesalamine: A randomized, controlled study. Am. J. Gastroenterol. 103, 2509 (2008).
150. L. Chessa, V. Leuzzi, A. Plebani, A. Soresina, R. Micheli, D. D'Agnano, T. Venturi, A. Molinaro, E. Fazzi, M. Marini, P. F. Leali, I. Quinti, F. M. Cavaliere, G. Girelli, M. C. Pietrogrande, A. Finocchi, S. Tabolli, D. Abeni, and M. Magnani, Intra-erythrocyte infusion of dexamethasone reduces neurological symptoms in ataxia teleangiectasia patients: Results of a phase 2 trial. Orphanet J. Rare Dis. 9, 5 (2014).
151. B. Gleich and J. Weizenecker, Tomographic imaging using the non-linear response of magnetic particles. Nature 435, 1214 (2005).
152. P. C. Lautembur, Image formation by induced local interactions: Examples employing nuclear magnetic resonance. Nature 242, 190 (1973).
153. J. Weizenecker, J. Borgert, and B. Gleich, A simulation study on the resolution and sensitivity of magnetic particle imaging. Phys. Med. Biol. 52, 6363 (2007).
154. B. Gleich, J. Weizenecker, and J. Borgert, Experimental results on fast 2D-encoded magnetic particle imaging. Phys. Med. Biol. 53, N81 (2008).
155. J. Weizenecker, B. Gleich, and J. Borgert, Magnetic particle imaging using a field free line. J. Phys. D: Appl. Phys. 41, 105009 (2008).
156. J. Borgert, J. D. Schmidt, I. Schmale, J. Rahmer, C. Bontus, B. Gleich, B. David, R. Eckart, O. Woywode, J. Weizenecker, J. Schnorr, M. Taupitz, J. Haegele, F. M. Vogt, and J. Barkhausen, Fundamentals and applications of magnetic particle imaging. J. Cardiovasc. Comput. Tomogr. 6, 149 (2012).
157. J. Rahmer, J. Weizenecker, B. Gleich, and J. Borgert, Analysis of a 3-D system function measured for magnetic particle imaging. IEEE Trans. Med. Imaging 31, 1289 (2012).
158. P. W. Goodwill, G. C. Scott, P. P. Stang, and S. M. Conolly, Narrowband magnetic particle imaging. IEEE Trans. Med. Imaging 28, 1231 (2009).
159. J. Haegele, J. Rahmer, B. Gleich, J. Borgert, H. Wojtczyk, N. Panagiotopoulos, T. M. Buzug, J. Barkhausen, and F. M. Vogt, Magnetic particle imaging: Visualization of instruments for cardiovascular intervention. Radiology 265, 933 (2012).
160. H. Wojtczyk, J. Haegele, M. Grüttner, W. Tenner, G. Bringout, M. Graeser, F. M. Vogt, J. Barkhausen, and T. M. Buzug, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 167-172.
161. G. Schütz, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 129-134.
162. J. Haegele, J. Rahmer, B. Gleich, C. Bontus, J. Borgert, H. Wojtczyk, T. M. Buzug, J. Barkhausen, and F. M. Vogt, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 211-215.
163. E. U. Saritas, P. W. Goodwill, L. R. Croft, J. J. Konkle, K. Lu, B. Zheng, and S. M. Conolly, Magnetic particle imaging (MPI) for NMR and MRI researchers. J. Magn. Reson. 229, 116 (2013).
164. P. W. Goodwill, E. U. Saritas, L. R. Croft, T. N. Kim, K. M. Krishnan, D. V. Schaffer, and S. M. Conolly, X-space MPI: Magnetic nanoparticles for safe medical imaging. Adv. Mater. 24, 3870 (2012).
165. J. Haegele, S. Biederer, H. Wojtczyk, M. Gräser, T. Knopp, T. M. Buzug, J. Barkhausen, and F. M. Vogt, Toward cardiovascular interventions guided by magnetic particle imaging: First instrument characterization. Magn. Reson. Med. 69, 1761 (2013).
166. S. K. Nune, P. Gunda, P. K. Thallapally, Y. Y. Lin, M. L. Forrest, and C. J. Berkland, Nanoparticles for biomedical imaging. Expert Opin. Drug Deliv. 6, 1175 (2009).
167. D. E. Sosnovik, M. Nahrendorf, and R. Weissleder, Magnetic nanoparticles for MR imaging: Agents, techniques and cardiovascular applications. Basic Res. Cardiol. 103, 122 (2008).
168. S. Laurent and M. Mahmoudi, Superparamagnetic iron oxide nanoparticles: Promises for diagnosis and treatment of cancer. Int. J. Mol. Epidemiol. Genet. 2, 367 (2011).
169. B. Gleich, Principles and Applications of Magnetic Particle Imaging, Aktuelle Forschung Medizintechnik, Springer Fachmedien, Wiesbaden (2014).
170. R. M. Ferguson, K. R. Minard, and K. M. Krishnan, Optimization of nanoparticle core size for magnetic particle imaging. J. Magn. Magn. Mater. 321, 1548 (2009).
171. A. P. Khandhar, R. M. Ferguson, H. Arami, and K. M. Krishnan, Monodisperse magnetite nanoparticle tracers for in vivo magnetic particle imaging. Biomaterials 34, 3837 (2013).
172. R. M. Ferguson, A. P. Khandhar, and K. M. Krishnan, Tracer design for magnetic particle imaging (invited). J. Appl. Phys. 111, 7B318 (2012).
173. R. M. Ferguson, K. R. Minard, A. P. Khandhar, and K. M. Krishnan, Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. Med. Phys. 38, 1619 (2011).
174. H. Arami, R. M. Ferguson, A. P. Khandhar, and K. M. Krishnan, Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environments. Med. Phys. 40, 071904 (2013).
175. K. Lüdtke-Buzug, J. Haegele, S. Biederer, T. F. Sattel, M. Erbe, R. L. Duschka, J. Barkhausen, and F. M. Vogt, Comparison of commercial iron oxide-based MRI contrast agents with synthesized high-performance MPI tracers. Biomed. Tech. (Berl.) 58, 527 (2013).
176. Y. Du, P. T. Lai, C. H. Leung, and P. W. Pong, Design of superparamagnetic nanoparticles for magnetic particle imaging (MPI). Int. J. Mol. Sci. 14, 18682 (2013).
177. R. Lawaczeck, H. Bauer, T. Frenzel, M. Hasegawa, Y. Ito, K. Kito, N. Miwa, H. Tsutsui, H. Vogler, and H. J. Weinmann, Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Pre-clinical profile of SH U555A. Acta Radiol. 38, 584 (1997).
178. J. Weizenecker, B. Gleich, J. Rahmer, H. Dahnke, and J. Borgert, Three-dimensional real-time in vivo magnetic particle imaging. Phys. Med. Biol. 54, L1 (2009).
179. I. Schmale, J. Rahmer, B. Gleich, J. Kanzenbach, J. D. Schmidt, C. Bontus, O. Woywode, and J. Borgert, Medical Imaging 2011: Biomedical Applications in Molecular, Structural, and Functional Imaging, edited by J. B. Weaver and R. C. Molthen, SPIE, Bellingham (2011) Vol. 7965, p. 796510.
180. K. M. Krishnan, Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy. IEEE Trans. Magn. 46, 2523 (2010).
181. T. Knopp, S. Biederer, T. F. Sattel, M. Erbe, and T. M. Buzug, Prediction of the spatial resolution of magnetic particle imaging using the modulation transfer function of the imaging process. IEEE Trans. Med. Imaging 30, 1284 (2011).
182. P. W. Goodwill, A. Tamrazian, L. R. Croft, C. D. Lu, E. M. Johnson, R. Pidaparthi, R. M. Ferguson, A. P. Khandhar, K. M. Krishnan, and S. M. Conolly, Ferrohydrodynamic relaxometry for magnetic particle imaging. Appl. Phys. Lett. 98, 262502 (2011).
183. T. M. Buzug, G. Bringout, M. Erbe, K. Gräfe, M. Graeser, M. Grüttner, A. Halkola, T. F. Sattel, W. Tenner, H. Wojtczyk, J. Haegele, F. M. Vogt, J. Barkhausen, and K. Lüdtke-Buzug, Magnetic particle imaging: Introduction to imaging and hardware realization. Z. Med. Phys. 22, 323 (2012).
184. P. Reimer, E. J. Rummeny, H. E. Daldrup, T. Balzer, B. Tombach, T. Berns, and P. E. Peters, Clinical results with Resovist: A phase 2 clinical trial. Radiology 195, 489 (1995).
185. D.-X. Chen, N. Sun, and H.-C. Gu, Size analysis of carboxydextran coated superparamagnetic iron oxide particles used as contrast agents of magnetic resonance imaging. J. Appl. Phys. 106, 063906 (2009).
186. D. Eberbeck, F. Wiekhorst, S. Wagner, and L. Trahms, How the size distribution of magnetic nanoparticles determines their magnetic particle imaging performance. Appl. Phys. Lett. 98, 182502 (2011).
187. J. B. Weaver, A. M. Rauwerdink, C. R. Sullivan, and I. Baker, Frequency distribution of the nanoparticle magnetization in the presence of a static as well as a harmonic magnetic field. Med. Phys. 35, 1988 (2008).
188. S. Biederer, T. F. Sattel, T. Knopp, K. Lüdtke-Buzug, B. Gleich, J. Weizenecker, J. Borgert, and T. M. Buzug, Magnetic Resonance Materials in Physics, Biology and Medicine, edited by P. J. Cozzone, Springer, Berlin, Heidelberg (2009), Vol. 22, p. 499.
189. J. Borgert, B. Gleich, J. Rahmer, H. Dahnke, and J. Weizenecker, Three-dimensional real-time in vivo magnetic particle imaging. Medicamundi 53, 48 (2009).
190. W. C. W. Chan (ed.), Bio-Applications of Nanoparticles, Landes Bioscience, Springer Science + Business Media, New York (2007).
191. D. Markov, H. Boeve, B. Gleich, J. Borgert, A. Antonelli, C. Sfara, and M. Magnani, Magnetic nanoparticles. Particles Science, Imaging Technology, and Clinical Application, edited by T. M. Buzug, J. Borgert, T. Knopp, S. Biederer, T. F. Sattel, M. Erbe, and K. Lüdtke-Buzug, World Scientific Publishing Co. Pte. Ltd., Singapore (2010), pp. 26-31.
192. S. Biederer, T. F. Sattel, T. Knopp, K. Lüdtke-Buzug, B. Gleich, J. Weizenecker, J. Borgert, and T. M. Buzug, 4th European Conference of the International Federation for Medical and Biological Engineering, edited by J. V. Sloten, P. Verdonck, M. Nyssen, and J. Haueisen, Springer-Verlag, Berlin, Heidelberg (2008), Vol. 22, pp. 2313-2316.
193. S. Biederer, T. Knopp, T. F. Sattel, K. Lüdtke-Buzug, B. Gleich, J. Weizenecker, J. Borgert, and T. M. Buzug, Magnetization response spectroscopy of superparamagnetic nanoparticles for magnetic particle imaging. J. Phys. D: Appl. Phys. 42, 205007 (2009).
194. F. Ludwig, T. Wawrzik, and M. Schilling, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 35-40.
195. T. Wawrzik, M. Schilling, and F. Ludwig, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 41-45.
196. S. Foner, Versatile and sensitive vibrating-sample magnetometer. Rev. Sci. Instrum. 30, 548 (1959).
197. S. Foner, Further improvements in vibrating sample magnetometer sensitivity. Rev. Sci. Instrum. 46, 1425 (1975).
198. V. A. Fassel and R. N. Kniseley, Inductively coupled plasma. Optical emission spectroscopy. Anal. Chem. 46, 1110A (1974).
199. J. Weizenecker, B. Gleich, J. Rahmer, and J. Borgert, Micromagnetic simulation study on the magnetic particle imaging performance of anisotropic mono-domain particles. Phys. Med. Biol. 57, 7317 (2012).
200. A. Antonelli, C. Sfara, M. Magnani, J. Rahmer, B. Gleich, J. Borgert, and J. Weizenecker, Magnetic Particle Imaging, SPPHY, edited by T. M. Buzug and J. Borgert, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140, pp. 175-179.
201. J. Rahmer, A. Antonelli, C. Sfara, B. Tiemann, B. Gleich, M. Magnani, J. Weizenecker, and J. Borgert, Nanoparticle encapsulation in red blood cells enables blood-pool magnetic particle imaging hours after injection. Phys. Med. Biol. 58, 3965 (2013).
202. C. Sfara, A. Antonelli, and M. Magnani, Erythrocytes as vascular carriers of superparamagnetic nanoparticle contrast agents. Bio. Tech. International 23, 6 (2011).
203. A. Antonelli, C. Sfara, J. Rahmer, B. Gleich, J. Borgert, and M. Magnani, Red blood cells as carriers in magnetic particle imaging. Biomed. Tech. (Berl.) 58, 517 (2013).
204. J. R. DeLoach, Dialysis method for entrapment of proteins into resealed red blood cells. Methods Enzymol. 149, 235 (1987).
205. M. H. Pablico-Lansigan, S. F. Situ, and A. C. S. Samia, Magnetic particle imaging: Advancements and perspectives for real-time in vivo monitoring and image-guided therapy. Nanoscale 5, 4040 (2013).
206. T. Knopp and T. M. Buzug (eds.), Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation, Springer-Verlag, Berlin, Heidelberg (2012).
207. T. M. Buzug and J. Borgert (eds.), Magnetic Particle Imaging: A Novel SPIO Imaging Technique, SPPHY, Springer-Verlag, Berlin, Heidelberg (2012), Vol. 140.